B. Riley Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,376
Closed -$319K 642
2021
Q4
$319K Sell
2,376
-116
-5% -$16.7K 0.02% 457
2021
Q3
$341K Buy
+2,492
New +$314K 0.03% 424

Other funds holding DXCM

B. Riley Wealth Management's DXCM Position: Q1 2022 in Review

B. Riley Wealth Management sold out of DexCom (DXCM) in Q1 2022, closing a stake of 2,376 shares — an estimated $319K sold.

B. Riley Wealth Management first reported a position in DXCM in Q3 2021 and held it in 2 quarters. The position peaked at $341K in Q3 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • B. Riley Wealth Management reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • B. Riley Wealth Management sold 2,376 DexCom shares in Q1 2022, an estimated $319K.
  • B. Riley Wealth Management first reported a position in DexCom in Q3 2021 and held it in 2 quarters.
  • B. Riley Wealth Management's DexCom position peaked at $341K in Q3 2021.
  • 861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on B. Riley Wealth Management's 13F filing for Q1 2022, filed 10 May 2022.